The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and ...

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical and basic science investigations, continuing education articles, state-of-the-art reviews, employment opportunities, and updates on rapidly changing issues in ...

Editorial Policy. The Journal of Nuclear Medicine (JNM) publishes material of interest to practitioners and scientists in the fields of nuclear medicine and molecular imaging.Proffered articles describing original laboratory or clinical investigations, brief communications, and letters to the editor will be considered for publication.

PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177 Lu-PSMA-617: Importance of 18 F-FDG–Avid Discordant Findings

Jan 8, 2025 · The Alzheimer’s Association and the Society of Nuclear Medicine and Molecular Imaging convened a multidisciplinary workgroup to update appropriate use criteria (AUC) for amyloid positron emission tomography (PET) and to develop AUC for tau PET. Methods: The workgroup identified key research questions that guided a systematic literature review on clinical amyloid/tau PET. Building on this ...

Feb 3, 2025 · Volume 66 Number 2 Feburary 2025 DISCUSSIONS WITH LEADERS 163 From Scientist to Analyst to Strategist Aharon(Ronny)Gal,KenHerrmann,andJohannesCzernin THE STATE OF THE ART 166 Dosimetry Software for Theranostic Applications: Current Capabilities and Future Prospects

View or Listen to JNM Podcast; Visit JNM on Facebook; Join JNM on LinkedIn; Follow JNM on Twitter; Subscribe to our RSS feeds

Jan 1, 2025 · Radionuclides used for imaging and therapy can show high molecular specificity in the body with appropriate targeting ligands. We hypothesized that local energy delivered by molecularly targeted radionuclides could chemically activate prodrugs at disease sites while avoiding activation in off-target sites of toxicity. As proof of principle, we tested whether this strategy of radionuclide ...

Only submit to https://submit-jnm.snmjournals.org/; Only emails from snmmi.org are official; No fees charged until after acceptance for publication; No external ...

Jan 16, 2025 · One of the most common clinical indications for amino acid PET using the tracer O -(2-[18F]-fluoroethyl)-l-tyrosine (18F-FET) is the differentiation of tumor relapse from treatment-related changes in patients with gliomas. A subset of patients may present with an uptake of 18F-FET close to recommended threshold values. The goal of this study was to investigate the frequency of borderline cases ...